Úplné zobrazení záznamu

Toto je statický export z katalogu ze dne 16.12.2023. Zobrazit aktuální podobu v katalogu.

Bibliografická citace

.
0 (hodnocen0 x )
EB
EB
ONLINE
Amsterdam : Elsevier, 2022
1 online resource
Externí odkaz    Plný text PDF 
   * Návod pro vzdálený přístup 


ISBN 9780323955751 (ePub ebook) :
ISBN 0323955754 (ePub ebook) :
ISBN 9780323955744
ISBN 0323955746
Drug Discovery Update
Print version: ISBN 9780323955744
PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS 1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations 2. Plants with potent antiviral properties 3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions 4. Herbs and drugs in clinical trials for coronavirus treatments 5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases 6. Dietary polyphenols as therapeutic agents to combat COVID-19 7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2 8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019 9. Food sources of natural antioxidants for body defence against SARS-CoV-2 10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection
Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19. Sections in this volume present chapters that focus on the various antiviral agents from natural products that have the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured are the dietary sources of antioxidant bioactives that may help boost the immune system for the management of COVID-19. Other chapters describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19. Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry..
001932460
(OCoLC)1346316633
GBC287144

Zvolte formát: Standardní formát Katalogizační záznam Zkrácený záznam S textovými návěštími S kódy polí MARC